A detailed history of Massmutual Trust CO Fsb transactions in Veracyte, Inc. stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 37 shares of VCYT stock, worth $1,520. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37
Previous 56 33.93%
Holding current value
$1,520
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024

SELL
$21.0 - $35.25 $399 - $669
-19 Reduced 33.93%
37 $1,000
Q2 2024

Jul 02, 2024

BUY
$18.86 - $23.55 $943 - $1,177
50 Added 833.33%
56 $1,000
Q1 2024

Apr 09, 2024

BUY
$21.0 - $29.1 $126 - $174
6 New
6 $0
Q3 2023

Oct 03, 2023

BUY
$22.33 - $29.92 $803 - $1,077
36 New
36 $0
Q3 2022

Oct 07, 2022

BUY
$16.58 - $27.9 $1,342 - $2,259
81 New
81 $1,000
Q2 2022

Jul 07, 2022

SELL
$15.45 - $29.52 $339 - $649
-22 Closed
0 $0
Q1 2022

Apr 08, 2022

BUY
$21.94 - $42.51 $482 - $935
22 New
22 $1,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.94B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Massmutual Trust CO Fsb Portfolio

Follow Massmutual Trust CO Fsb and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Massmutual Trust CO Fsb with notifications on news.